KFS
Kurt F. Somerville Portfolio holdings
AUM
$594M
This Quarter Return
-14.38%
1 Year Return
+12.39%
3 Year Return
+68.79%
5 Year Return
+108.17%
10 Year Return
+271.21%
AUM
$451M
AUM Growth
+$451M
(-15%)
Cap. Flow
+$3.24M
Cap. Flow
% of AUM
0.72%
Top 10 Holdings %
Top 10 Hldgs %
37.62%
Holding
113
New
17
Increased
43
Reduced
31
Closed
8
Top Buys
| 1 |
UnitedHealth
UNH
|
$2.03M |
| 2 |
Johnson & Johnson
JNJ
|
$1.26M |
| 3 |
Becton Dickinson
BDX
|
$982K |
| 4 |
Amazon
AMZN
|
$883K |
| 5 |
Union Pacific
UNP
|
$846K |
Top Sells
| 1 |
3M
MMM
|
$4.16M |
| 2 |
Apple
AAPL
|
$2.68M |
| 3 |
IPG Photonics
IPGP
|
$2.25M |
| 4 |
Fiserv
FI
|
$1.25M |
| 5 |
Mastercard
MA
|
$766K |
Sector Composition
| 1 | Healthcare | 24.94% |
| 2 | Technology | 22.81% |
| 3 | Industrials | 11.66% |
| 4 | Financials | 8.58% |
| 5 | Consumer Staples | 8.26% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Illumina
ILMN
$15.5B
| $6.42M | 1.42% |
23,523
+676
| +3% | +$185K |
|
27
Xylem
XYL
$34.5B
| $6.27M | 1.39% |
96,258
+3,563
| +4% | +$232K |
|
|
28
Becton Dickinson
BDX
$53.9B
| $6.17M | 1.37% |
26,831
+4,275
| +19% | +$982K |
|
|
29
3M
MMM
$82.2B
| $5.88M | 1.3% |
43,057
-30,479
| -41% | -$4.16M |
|
30
PepsiCo
PEP
$206B
| $5.15M | 1.14% |
42,882
+527
| +1% | +$63.3K |
|
31
Chevron
CVX
$326B
| $4.58M | 1.02% |
63,268
+5,478
| +9% | +$397K |
|
32
Fortive
FTV
$16.2B
| $3.54M | 0.79% |
64,203
+4,607
| +8% | +$254K |
|
33
Exxon Mobil
XOM
$489B
| $3.03M | 0.67% |
79,806
+8,763
| +12% | +$333K |
|
34
Merck
MRK
$214B
| $2.04M | 0.45% |
26,542
+6,612
| +33% | +$508K |
|
|
35
UnitedHealth
UNH
$280B
| $2.03M | 0.45% |
+8,147
| New | +$2.03M |
|
|
36
Union Pacific
UNP
$132B
| $1.9M | 0.42% |
13,440
+6,000
| +81% | +$846K |
|
37
NVIDIA
NVDA
$4.16T
| $1.7M | 0.38% |
6,465
-50
| -0.8% | -$13.2K |
|
|
38
IPG Photonics
IPGP
$3.45B
| $1.62M | 0.36% |
14,670
-20,385
| -58% | -$2.25M |
|
39
EOG Resources
EOG
$68.8B
| $1.59M | 0.35% |
44,316
+15,680
| +55% | +$563K |
|
40
AbbVie
ABBV
$374B
| $1.57M | 0.35% |
20,575
-850
| -4% | -$64.8K |
|
41
Colgate-Palmolive
CL
$67.9B
| $1.47M | 0.33% |
22,151
+322
| +1% | +$21.4K |
|
42
General Mills
GIS
$26.4B
| $1.35M | 0.3% |
25,475
-800
| -3% | -$42.3K |
|
43
Ormat Technologies
ORA
$5.5B
| $1.23M | 0.27% |
18,175
+2,020
| +13% | +$137K |
|
44
Visa
V
$679B
| $1.17M | 0.26% |
7,285
+1,600
| +28% | +$258K |
|
45
Novo Nordisk
NVO
$251B
| $1.04M | 0.23% |
17,335
-465
| -3% | -$28K |
|
46
Berkshire Hathaway Class B
BRK.B
$1.08T
| $1.01M | 0.22% |
5,529
-268
| -5% | -$49.1K |
|
47
Coca-Cola
KO
$297B
| $978K | 0.22% |
22,105
+6,300
| +40% | +$279K |
|
48
Norfolk Southern
NSC
$62.4B
| $954K | 0.21% |
6,530
-624
| -9% | -$91.2K |
|
49
Pfizer
PFE
$142B
| $938K | 0.21% |
28,748
+1,570
| +6% | +$51.2K |
|
50
Eli Lilly
LLY
$659B
| $909K | 0.2% |
6,550
+1,110
| +20% | +$154K |
|